PolyPid
PYPD
14 hedge funds and large institutions have $7.5M invested in PolyPid in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
17% more funds holding
Funds holding: 12 → 14 (+2)
13% more capital invested
Capital invested by funds: $6.64M → $7.5M (+$863K)
3.71% less ownership
Funds ownership: 40.05% → 36.34% (-3.7%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$1.11M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$487K |
| 3 |
JGC
J. Goldman & Co
New York
|
+$422K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.74K |
| 5 |
Morgan Stanley
New York
|
+$329 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$115K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$56.6K |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$45.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.54K |
| 5 |
GSEP
Golden State Equity Partners
South Coast Metro,
California
|
-$309 |
PYPD Hedge Fund Activity: Q4 2024 in Review
14 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q4 2024, worth a combined $7.5M — up 13% from $6.64M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PYPD positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Rosalind Advisors, adding an estimated $1.11M. The largest seller was Stonepine Capital Management, cutting an estimated $115K.
- 14 institutional investors held PolyPid (PYPD) as of Q4 2024, up from 12 in Q3 2024.
- Funds reported $7.5M of PolyPid stock for Q4 2024, up 13% quarter-over-quarter.
- 3 funds opened new PolyPid positions in Q4 2024 and 1 closed out, a net change of +2 holders.
- The largest PolyPid buyer in Q4 2024 was Rosalind Advisors, an estimated $1.11M added.
- The largest PolyPid seller in Q4 2024 was Stonepine Capital Management, an estimated $115K sold.
Based on aggregated 13F filings for Q4 2024.